Literature DB >> 16998862

The natural history of overactive bladder and stress urinary incontinence in older women in the community: a 3-year prospective cohort study.

M M K Donaldson1, J R Thompson, R J Matthews, H M Dallosso, C W McGrother.   

Abstract

AIMS: This is the first study designed to describe the natural history of stress urinary incontinence (SUI) and overactive bladder (OAB), using validated symptom syndrome severity scores developed for the purpose.
METHODS: Two separate but related studies were involved, (i) a clinic sample (N = 2,052) from a randomised controlled trial (RCT) and (ii) a prospective cohort study (N = 12,750) with 3-year follow-up. Subjects in both studies were women aged 40 or more living in the community, approached using similar postal questionnaires. Severity scores using standardised urinary symptoms were derived for SUI and OAB from weightings obtained from logistic regression models of symptoms in relation to urodynamic diagnosis. Symptom severity scores were plotted for baseline and 3 years of follow-up to demonstrate the natural history of the main categories of SUI and OAB.
RESULTS: Overactive bladder and SUI syndrome severity scores showed good criterion validity in relation to relevant clinical measures and good test-retest reliability. OAB severity increased progressively with age including a period of accelerated increase in the 60s. In contrast, SUI severity showed two age-related peaks around age 60 and again at age 80. SUI severity also showed a more fluctuating pattern from year to year compared to OAB.
CONCLUSIONS: Contrasting patterns of natural history for OAB and SUI syndromes were identified consistent with differences in the patterns of related co-morbidities. Further studies are needed to confirm these findings. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16998862     DOI: 10.1002/nau.20235

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  9 in total

1.  CUA guideline on adult overactive bladder.

Authors:  Jacques Corcos; Mikolaj Przydacz; Lysanne Campeau; Gary Gray; Duane Hickling; Christiane Honeine; Sidney B Radomski; Lynn Stothers; Adrian Wagg; Frcp Lond
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

2.  Longitudinal changes in overactive bladder and stress incontinence among parous women.

Authors:  Victoria L Handa; Christopher B Pierce; Alvaro Muñoz; Joan L Blomquist
Journal:  Neurourol Urodyn       Date:  2014-03-14       Impact factor: 2.696

3.  Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome.

Authors:  Ghazaleh Rostaminia; Cecilia Chang; Joseph B Pincus; Peter K Sand; Roger P Goldberg
Journal:  Int Urogynecol J       Date:  2018-11-29       Impact factor: 2.894

4.  Does transition of urinary incontinence from one subtype to another represent progression of the disease?

Authors:  Vatché A Minassian; Xiaowei Yan; Anna L Pilzek; Raisa Platte; Walter F Stewart
Journal:  Int Urogynecol J       Date:  2018-03-13       Impact factor: 2.894

Review 5.  Oestrogen therapy for urinary incontinence in post-menopausal women.

Authors:  June D Cody; Madeleine Louisa Jacobs; Karen Richardson; Birgit Moehrer; Andrew Hextall
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 6.  Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.

Authors:  Linda D Cardozo; Philip E V A Van Kerrebroeck; David R Staskin
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

Review 7.  Why do stress and urge incontinence co-occur much more often than expected?

Authors:  Vatche A Minassian; Walter F Stewart; Annemarie G Hirsch
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-05

8.  Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.

Authors:  Jean-Jacques Wyndaele
Journal:  Int J Gen Med       Date:  2012-11-12

9.  Postmenopausal overactive bladder.

Authors:  Jacek Tomaszewski
Journal:  Prz Menopauzalny       Date:  2014-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.